136 related articles for article (PubMed ID: 21260998)
1. [Influenza virus reproduction in the MDCK cells adapted to growth in serum-free Hybris-2 medium].
Podcherniaeva RIa; Baklanova OV; Glushchenko LA; Isaeva EI; Chestkov VV; Tabakov VIu; Mikhaĭlova GR
Vopr Virusol; 2010; 55(5):47-9. PubMed ID: 21260998
[TBL] [Abstract][Full Text] [Related]
2. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
4. [Development of a live culture of cold-adapted reassortant influenza vaccines].
Gendon IuZ; Markushin SG; Akopova II; Koptiaeva NB; Isachenko AA; Mazurkova NA; Nechaeva EA
Vopr Virusol; 2003; 48(2):12-7. PubMed ID: 12924092
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of reproduction of influenza virus strains in cell lines perspective for the creation of cultural vaccines grown on nutrient medium on the basis of rise flour protein hydrolysate.
Mazurkova NA; Troshkova GP; Sumkina TP; Kolokol'tsova TD; Skarnovich MO; Kabanov AS; Shishkina LN; Sergeev AN
Bull Exp Biol Med; 2008 Oct; 146(4):547-50. PubMed ID: 19489339
[TBL] [Abstract][Full Text] [Related]
6. Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.
Huang D; Peng WJ; Ye Q; Liu XP; Zhao L; Fan L; Xia-Hou K; Jia HJ; Luo J; Zhou LT; Li BB; Wang SL; Xu WT; Chen Z; Tan WS
PLoS One; 2015; 10(11):e0141686. PubMed ID: 26540170
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
Voeten JT; Claas EC; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD
Dev Biol Stand; 1999; 98():77-87; discussion 89-90. PubMed ID: 10494961
[TBL] [Abstract][Full Text] [Related]
8. [Further development (MDCK) of live cold-adapted influenza vaccine: cultivation of vaccine strains in production fermenters].
Gendon IuZ; Markushin SG; Akopova II; Koptiaeva IB; Nechaeva EA; Mazurkova IA; Radaeva IF; Kolokol'tsova TD
Vopr Virusol; 2005; 50(2):4-9. PubMed ID: 15881389
[TBL] [Abstract][Full Text] [Related]
9. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
[TBL] [Abstract][Full Text] [Related]
10. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium.
Voeten JT; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD; Claas EC
Vaccine; 1999 Apr; 17(15-16):1942-50. PubMed ID: 10217593
[TBL] [Abstract][Full Text] [Related]
11. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
12. [The effect of different factors on the reproduction of influenza viruses and reassortants in cell cultures].
Podcherniaeva RIa; Danlybaeva GA
Vopr Virusol; 1991; 36(5):384-6. PubMed ID: 1803770
[TBL] [Abstract][Full Text] [Related]
13. Isolation of influenza A and B viruses in HeLa cells.
Yamanaka T; Shirasawa H; Yoshizawa S
Microbiol Immunol; 1995; 39(5):361-3. PubMed ID: 7565177
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a porcine intestinal epithelial cell line for influenza virus production.
Sun Z; Huber VC; McCormick K; Kaushik RS; Boon ACM; Zhu L; Hause B; Webby RJ; Fang Y
J Gen Virol; 2012 Sep; 93(Pt 9):2008-2016. PubMed ID: 22739061
[TBL] [Abstract][Full Text] [Related]
15. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
16. Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
Chu C; Lugovtsev V; Lewis A; Betenbaugh M; Shiloach J
Vaccine; 2010 Oct; 28(44):7193-201. PubMed ID: 20800699
[TBL] [Abstract][Full Text] [Related]
17. Growth characteristics of canine pathogenic viruses in MDCK cells cultured in RPMI 1640 medium without animal protein.
Mochizuki M
Vaccine; 2006 Mar; 24(11):1744-8. PubMed ID: 16271422
[TBL] [Abstract][Full Text] [Related]
18. Madin-Darby canine kidney cell sialic acid receptor modulation induced by culture medium conditions: Implications for the isolation of influenza A virus.
Nelson SW; Lorbach JN; Nolting JM; Stull JW; Jackwood DJ; Davis IC; Bowman AS
Influenza Other Respir Viruses; 2019 Nov; 13(6):593-602. PubMed ID: 31392833
[TBL] [Abstract][Full Text] [Related]
19. Production of influenza virus in serum-free mammalian cell cultures.
Merten OW; Manuguerra JC; Hannoun C; van der Werf S
Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
[TBL] [Abstract][Full Text] [Related]
20. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
